VANCOUVER, BC – March 21, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its ambassador marketing program for neuenergy®.
The Company has been beta testing the program for several months, and it is now being opened to ambassadors around the world, with an initial focus on North America, Europe and Southeast Asia.
The neuenergy® Ambassador Marketing Program (NAMP), allows the Company to build out a network of influencers, public figures, celebrities and entrepreneurs to help expand the neuenergy® brand. Commissions are earned from online sales that are generated from the direct referral of the Ambassador. This program is ideal for influencers, public figures, celebrities and entrepreneurs that the Company identifies as a good fit for the brand and product. It will give them the opportunity to monetize their social networks by generating sales of neuenergy® through their own referral network.
NeutriSci President Mr. Glen Rehman stated, “A solid brand ambassador program creates mutual benefits with cost-effective promotion for both parties. Ambassadors boost brand awareness in the target market and drive sales in a less expensive way than traditional channels. Our Ambassador program will promote trusted faces thus positively reinforcing neuenergy to their readers and followers. Ambassadors benefit because they receive commission on every sale they refer however these commissions only come from customers who convert, so both businesses and ambassadors benefit from a transparent and efficient working arrangement. We are very excited about the level of interest this program has already achieved, and look forward to announcing industry leading Ambassadors over the next few weeks.”
Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.
To find out more about neuenergy®, please visit www.getneuenergy.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
Tel: (403) 264-6320
For investor relations inquiries:
Skanderbeg Capital Advisors
O: 604‐687‐7130 x105
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.